IMA
NASDAQ · Pharmaceuticals
Imagenebio Inc
$5.66
-0.36 (-5.98%)
Open$5.97
Previous Close$6.02
Day High$6.21
Day Low$5.65
52W High$18.00
52W Low$3.94
Volume—
Avg Volume71.9K
Market Cap66.10M
P/E Ratio—
EPS$-4.45
SectorPharmaceuticals
Analyst Ratings
Buy
7 analysts
Price Target
+112.4% upside
Current
$5.66
$5.66
Target
$12.02
$12.02
$8.98
$12.02 avg
$15.27
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 1.92M | 5.16M | 44.29M |
| Net Income | -108,734,138 | -263,491,449 | 4.55M |
| Profit Margin | -5,668.6% | -5,385.2% | 10.3% |
| EBITDA | -113,495,680 | -290,309,359 | 9.89M |
| Free Cash Flow | — | — | 3.33M |
| Rev Growth | -62.9% | -62.9% | -0.9% |
| Debt/Equity | — | — | 0.50 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $948.45 | -2.72% | 36.1 | 913.24B |
| JNJ | Johnson & Johnson | $221.32 | -0.53% | 26.1 | 548.94B |
| MRK | Merck & Co. Inc. | $111.38 | -0.82% | 31.3 | 279.42B |
| PFE | Pfizer Inc. | $25.68 | -3.02% | 19.3 | 150.09B |
| BMY | Bristol-Myers Squibb Co | $56.16 | -0.16% | 17.0 | 120.08B |
| ZTS | Zoetis Inc | $82.83 | -5.13% | 21.5 | 57.37B |